novel multiple-stage antimalarial agent inhibits protein synthesis 
urgent need new drugs treat malaria broad therapeutic potential novel modes action widen scope treatment overcome emerging drug resistance describe discovery ddd107498 compound potent novel spectrum antimalarial activity multiple life-cycle stages plasmodium parasite good pharmacokinetic properties acceptable safety profile ddd107498 demonstrates potential address variety clinical needs including single-dose treatment transmission blocking chemoprotection ddd107498 developed screening programme blood-stage malaria parasites molecular target identified translation elongation factor eef2 responsible gtp-dependent translocation ribosome along messenger rna essential protein synthesis discovery eef2 viable antimalarial drug target opens new possibilities drug discovery 
